European Archives - Page 11 of 1121 - European Medical Journal

Menstrual Cycle May Influence Inflammation in Women with Sickle Cell Disease

A recent study has found that women with sickle cell disease experience higher inflammation during the follicular phase of their menstrual cycle, which may explain the timing of pain episodes and offer insight into more personalised care.

Adequate mitomycin C can effectively reduce recurrence and progression in patients with IR NMIBC – the value of maintenance therapy*

This episode explores the treatment of patients with intermediate-risk non-muscle-invasive bladder cancer (IR NMIBC), an important topic…

Semaglutide Shows Promise in Treating MASH and Liver Fibrosis

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

New Screening Model Enhances Hepatitis Care Access: EASL 2025

The study concludes that decentralised and person-centred hepatitis screening is effective and essential.

BMS names Cari Gallman as new General Counsel

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 years.

Restoring T Cell Autophagy Reduces Liver Fibrosis Progression

A new study sheds light on the role of CD4 T cell autophagy, a cellular recycling process, in the progression of liver fibrosis.

AI Enhances Fracture Risk Prediction in Women Who Are Postmenopausal: WCO 2025

Researchers from the OsteoLaus cohort have developed a machine learning model to predict fragility fractures in postmenopausal women using bone and body composition data.

New Driver of Inflammation Found in Ulcerative Colitis

Clinically, this discovery could reshape the understanding of immune regulation in ulcerative colitis.

Managing Atopic Dermatitis in Infants

Restoring the skin barrier is key in managing and potentially preventing atopic dermatitis.

The word spotlight on a blue background

Spotlight: April 2025

From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.